Global Nanomedicine Market Report and Forecast 2024-2032

Global Nanomedicine Market Outlook

The global nanomedicine market size attained a value of USD 266.84 billion in 2023. The market is anticipated to grow at a CAGR of 11.6% during the forecast period of 2024-2032 to attain a value of USD 716.51 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Demand for Nanomedicines to Augment the Market Growth

The increase in the demand for nanomedicines can be attributed to the rapidly increasing applications of nanomaterials like nanocapsules as well as nanotubes in drug delivery systems. The demand for nanomedicines is further aided by the increase in the incidences of cancer and cardiovascular diseases, leading to the growth of public and private investments in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side-effects of these therapies are also major drivers of the nanomedicine industry growth.

North America to be a Significant Regional Market for Nanomedicine with the Asia Pacific Being One of the Fastest Growing Markets

Due to substantial government spending on nanomedicine research in the United States, the North American nanomedicine industry is expected to be one of the leading markets for nanomedicine in the forecast period of 2024-2032. The increased availability of patented nanomedicine items is credited with the region's growth. In addition to a well-developed healthcare infrastructure and a significant incidence of cancer, nanomedicine is easily accessible in this region, which has aided the market growth further.

The large geriatric population in the Asia Pacific is witnessing high incidence rates of cancer and cardiovascular diseases, which is expected to boost the nanomedicine market in the region. The regional market is expected to be one of the fastest growing markets for nanomedicine. The market growth in the Asia Pacific is expected to be aided by the increase in research grants to tackle life-threatening diseases, with countries like China and Japan leading the way.

Nanomedicine: Market Segmentation

Nanomedicine is a segment of nanotechnology that is used to diagnose, treat, monitor, and regulate biological systems. It improves medicine delivery by manipulating materials at the nanoscale. As a result, nanomedicine has aided in the treatment of a variety of illnesses. Nanomedicine is still in its infancy, with numerous items under development. Nanobiotix has identified 230 nanomedicine products that are either marked or in the trial phase. Out of the 230 products, 49 are in the market, and 122 are in the clinical trial phases, either in Phase II or Phase III trials.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on product type, the market can be segmented into:

• Therapeutics
• Regenerative Medicine
• In-Vitro Diagnostics
• In-Vivo Diagnostics
• Vaccines

By application, the market is categorised into:

• Clinical Oncology
• Infectious Diseases
• Clinical Cardiology
• Orthopaedics
• Others

On the basis of nanomolecule type, the industry is categorised into:

• Nanoparticles and Quantum Dots
  • Metal and Metal Compounds
  • Liposomes
  • Polymer and Polymer Drug Conjugate
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
• Nanoshells
• Nanotubes
• Nanodevices

The major regional markets of nanomedicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Focus on Technological Advancements for Improved Healthcare Services to Bolster the Growth of the Nanomedicine Industry

Currently, the healthcare sector is one of the most important areas where nanotechnology has made significant progress in the detection and treatment of chronic diseases such as cancer, heart disease, and other disorders. Firms researching patch technologies have attracted significant financing as healthcare companies focus on transdermal insulin administration as the industry's emphasis is moving toward transdermal medication delivery. Further, the tailored medication delivery method is being emphasised heavily in order to reduce the risk of side effects. Bypassing the body's defence mechanisms, this method provides reachability with increased efficacy and minimum degradation. Such technological developments and investments are likely to propel the growth of the market in the coming years.

Key Industry Players in the Global Nanomedicine Market

The report gives a detailed analysis of the following key players in the global nanomedicine market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Arrowhead Pharmaceuticals, Inc.
• Nanospectra Biosciences, Inc.
• Ablynx N.V.
• AMAG Pharmaceuticals, Inc.
• Celgene Corporation
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report